NCT00312650View on ClinicalTrials.gov

Doxil and Gemcitabine in Recurrent Ovarian Cancer

PHASE2TerminatedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions

Ovarian Carcinoma

Interventions

DRUG

liposomal doxorubicin and gemcitabine

Trial Locations (1)

02905

Women and Infants' Hospital, Providence

Sponsors

Collaborators (1)

Ortho Biotech, Inc.

All Listed Sponsors

collaborator

Ortho Biotech, Inc.

INDUSTRY

lead

Women and Infants Hospital of Rhode Island

OTHER

NCT00312650 - Doxil and Gemcitabine in Recurrent Ovarian Cancer | Biotech Hunter | Biotech Hunter